Recent EPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:02:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/17/2024 12:00:27 PM
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 • PR Newswire (US) • 12/17/2024 12:00:00 PM
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 • PR Newswire (Canada) • 12/17/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2024 12:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 08:30:06 PM
- ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer • PR Newswire (Canada) • 11/01/2024 12:57:00 AM
- ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer • PR Newswire (US) • 11/01/2024 12:57:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2024 07:00:52 PM
- ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress • PR Newswire (Canada) • 09/13/2024 09:19:00 PM
- ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress • PR Newswire (US) • 09/13/2024 09:19:00 PM
- ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference • PR Newswire (Canada) • 09/11/2024 08:05:00 PM
- ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference • PR Newswire (US) • 09/11/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 06:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:57:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 11:01:43 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 11:00:44 AM
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 • PR Newswire (US) • 08/05/2024 11:00:00 AM
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 • PR Newswire (Canada) • 08/05/2024 11:00:00 AM
- ESSA Pharma to Present at the JonesHealthcare Seaside Summit • PR Newswire (Canada) • 07/08/2024 08:05:00 PM
- ESSA Pharma to Present at the JonesHealthcare Seaside Summit • PR Newswire (US) • 07/08/2024 08:05:00 PM
- ESSA Pharma to Present at the Jefferies Global Healthcare Conference • PR Newswire (US) • 05/30/2024 12:00:00 PM
- ESSA Pharma to Present at the Jefferies Global Healthcare Conference • PR Newswire (Canada) • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:01:47 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM